5HT₆ receptor antagonists: a patent update. Part 1. Sulfonyl derivatives

Author： Ivachtchenko Alexandre V Ivanenkov Yan A

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.22, Iss.8, 2012-08, pp. : 917-964

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

5-HT₆ receptor modulators: a patent update. Part 2. Diversity in heterocyclic scaffolds

By Ivachtchenko Alexandre V Ivanenkov Yan A Skorenko Andrey V

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 10, 2012-10 ,pp. : 1123-1168

Informa Healthcare

Access to resources Recommend Favorite

5-HT 1B/D Receptor Antagonists

By Pauwels P.J.

General Pharmacology, Vol. 29, Iss. 3, 1997-09 ,pp. : 293-303

Elsevier

Access to resources Recommend Favorite

Bradykinin B1 receptor antagonists: a patent update 2009 – 2012

By Bozó Éva Éles János Keserű György M

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 12, 2012-12 ,pp. : 1443-1452

Informa Healthcare

Access to resources Recommend Favorite

Recent progress in 5-HT6 receptor antagonists for the treatment of CNS diseases

By Slassi Abdelmalik Isaac Methvin O’Brien Anne

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 4, 2002-04 ,pp. : 513-527

Informa Healthcare

Access to resources Recommend Favorite

5-HT6 Receptor Antagonists as Potential Therapeutics for Cognitive Impairment

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 2, 2010-02 ,pp. : 207-221

Bentham Science Publishers

Access to resources Recommend Favorite